VAUGHAN, ON , Nov. 1, 2022 /PRNewswire/ — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the #LUMIFYEyeDance Problem on TikTok has received Business Intelligence Group’s (BIG) 2022 Public Relations and Marketing Excellence Award for External Campaign of the particular Year.

“The #LUMIFYEyeDance hashtag obtained approximately 20 million video views on TikTok – that’s six million more views than the LUMIFY hashtag had organically amassed on TikTok before the start of the campaign, ” said Joe Gordon , president, Global Consumer, Surgical plus Vision Care, Bausch + Lomb. “We are proud to receive this honor through Business intelligence (bi) Group as it is a testament to the uniqueness of the particular campaign, as well as the significant reach and authentic engagement that we were able to achieve throughout its duration. ”

The #LUMIFYEyeDance Challenge, which usually spanned from July twenty five, 2022 , to Aug. 31, 2022 , motivated consumers to post a video of on their own ‘dancing with their eyes’ to the beat of the LUMIFY audio track. Participants who posted videos using the two standard hashtags, #LUMIFYEyeDance and #WinIt, were instantly enrolled in a sweepstakes. The winner from the sweepstakes received travel and accommodations for two to  New York with regard to an A-List makeover along with celebrity makeup artist plus LUMIFY vision drops brand ambassador, Vincent Oquendo , amongst other prizes.

To support the Challenge, Bausch + Lomb also held the sampling tour that ran through Chicago , Dallas , Los Angeles and New York during the month of August. The day-long pop-up events at each location featured a LUMIFY branded tiny home that offered visitors refreshments and mini masterclass sessions taught by prominent local makeup artists. Visitors could also record their TikTok #LUMIFYEyeDance challenge videos at a selfie station.

Since launching in 2018, Bausch + Lomb LUMIFY eye drops have received more than a dozen awards, including Glamour’s “The Best Beauty Innovators of 2022” award. LUMIFY was also named to U. S. BASES Top 25 Breakthrough Innovations List.

For more information on LUMIFY, visit www.lumifydrops.com .  

About Business Cleverness Team

The Business Intelligence Group has been founded with the mission associated with recognizing true talent plus superior performance in the business world. Unlike some other industry and business honor programs , business executives—those with experience and knowledge—judge the programs. The organization’s proprietary plus unique scoring system selectively measures overall performance across multiple business domains and then rewards those companies whose achievements stand above those of their peers.

About LUMIFY® Redness Reliever Eye Drops

LUMIFY is the first and only over-the-counter eye drop formulated with low-dose brimonidine tartrate 0. 025% regarding the treatment of ocular redness. Unlike additional redness relievers, LUMIFY contains an unique formulation that selectively targets redness. In clinical trials, LUMIFY had been shown to have a reduced incidence of side effects common in order to other inflammation relievers, like rebound redness and loss of efficacy over time, when used as directed. LUMIFY is also the No . 1 attention doctor recommended redness reliever eye fall brand along with approximately 87% of doctor recommendations. ¹ 

Regarding Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the particular gift associated with sight intended for millions of people around the globe – through the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eyesight maintenance systems, ophthalmic pharmaceuticals, otc products and ophthalmic surgical devices and instruments. Founded within 1853, Bausch + Lomb has a significant global research and development, manufacturing plus commercial footprint with more than 12, 000 employees and a presence in nearly 100 countries. Bausch + Lomb will be headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey . For a lot more information, visit  www.bausch.com   and connect with us upon Twitter , LinkedIn , Facebook   and Instagram .

Forward-looking Statements

This news release may contain forward-looking statements, which may generally be identified simply by the use of the words “anticipates, inch “hopes, inches “expects, ” “intends, inch “plans, inches “should, ” “could, inch “would, inches “may, ” “believes, inch “estimates, inches “potential, ” “target, inch or “continue” and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks plus uncertainties that could cause actual results in order to differ materially from those described within the forward-looking statements. These types of risks and uncertainties include, but are not limited to, the risks plus uncertainties discussed in Bausch + Lomb’s filings with the U. S. Securities and Exchange Commission and the Canadian Investments Administrators, which factors are usually incorporated herein by reference. They furthermore include, but are not limited to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, as well as the fear associated with that pandemic and its potential effects, the particular severity, duration and future impact of which are highly uncertain and cannot be predicted, and which might have a material adverse impact on Bausch + Lomb, including but not limited in order to its project development timelines, launches plus costs (which may increase). Readers are usually cautioned not to place undue reliance on any of these forward-looking claims. These forward-looking statements speak only as of the date hereof. Bausch + Lomb  undertakes no obligation to update some of these forward-looking statements to reflect events or circumstances after the date of this news release or to reveal actual outcomes, unless required by law.  

References

1. IQVIA, Average Share associated with Weekly Doctor Recommendations, Q3 2022.  

LUMIFY is usually a   trademark of Bausch & Lomb Incorporated or the affiliates.
Any various other product/brand names and/or logos are trademarks of the respective owners.
© 2022 Bausch & Lomb Integrated or its affiliates.
LUM. 0255. USA. 22

SOURCE Bausch + Lomb Company